Found 93 matching trials
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female PHASE4 This study is to evaluate lot-lot consistency of Recombinant Human Papillom...
Show More Location
Dongtai City Center for Disease Control and Prevention Dongtai, Jiangsu
Learn More & Join Trial
Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. PHASE2 The main aim of this vaccine is to prevent cervical cancer in women. Howeve...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women PHASE3 Human papillomavirus infection has clearly been recognized as the cause of ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 PHASE3 Human Papilloma virus (HPV) are viruses that cause a common infection of th...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects PHASE3 Infection with human papillomavirus (HPV) has been clearly established as t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years PHASE3 Human papillomavirus infection has clearly been recognized as the cause of ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine PHASE3 This protocol posting deals with objectives \& outcome measures of the exte...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females PHASE3 The purpose of this study is to evaluate the immunogenicity and the safety ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study PHASE3 This extension study is conducted to assess the efficacy of the GSK 580299 ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older PHASE3 This is a multicentre study in which women were planned to receive either t...
Show More Location
GSK Investigational Site
Learn More & Join Trial